BAY-179

CAS No. 2764880-87-5

BAY-179( —— )

Catalog No. M37661 CAS No. 2764880-87-5

BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor used for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 53 In Stock
5MG 48 In Stock
10MG 77 In Stock
25MG 179 In Stock
50MG 271 In Stock
100MG 377 In Stock
200MG 500 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAY-179
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor used for cancer research.
  • Description
    BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor (IC50=79 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Mitochondrial Metabolism
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2764880-87-5
  • Formula Weight
    415.51
  • Molecular Formula
    C23H21N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (150.42 mM; Ultrasonic (<60°C)
  • SMILES
    C(N1CCC(C2=NC(C3=CC=4C(O3)=CC=CC4)=CS2)CC1)C=5NC=6C(N5)=NC=CC6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mowat J, et al. Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179. ACS Med Chem Lett. 2022;13(3):348-357. Published 2022 Feb 18. ?
molnova catalog
related products
  • 16alpha-Hydroxypredn...

    16alpha-Hydroxyprednisolone is a stereoselective metabolite of the 22(R) epimer of the glucocorticoid budesonide.

  • Tetracosane

    Tetracosane is a natural product isolated from the Bangladeshi medicinal plant Acrostichum aureum.

  • Dihydroxyfumaric aci...

    Dihydroxyfumaric acid is a known generator of superoxide anions and by hydroxyl free radicals. Dihydroxyfumarate exposure can cause insulin inhibitory effects. It can spontaneously convert to hydroxypyruvate or to oxaloglycolate.